Related Experiment Video
Updated: Aug 5, 2026

Therapeutic Massage for Psychological Well-being in Geriatric Oncology
Published on: May 22, 2026
The Importance of Minority Stress and Intersectionality for Cancer Symptom Management: The Case of Cancer-Related
Milena E Insalaco1, Oscar Y Franco-Rocha2, Laura Stamm3
1Division of Supportive Care in Cancer, Department of Surgery, University of Rochester Medical Center, Rochester, New York.
Abstract:
Although research demonstrates that cancer survivors who are sexual and gender minorities (SGM), racial and ethnic minorities, or of lower socioeconomic status experience a higher prevalence of cancer-related pain, limited studies have examined how these intersecting marginalized identities and additional social experiences interconnect and affect pain outcomes. In their recent study, Boehmer and colleagues conducted an intersectional analysis of cancer-related pain among SGM adults and other marginalized backgrounds. Using data from the Behavioral Risk Factor Surveillance System, they found that SGM individuals reported a higher prevalence of cancer-related pain. SGM adults with a history of cancer who were younger than 65 years, Black or Hispanic, had low income, unemployed, never or formerly married, and reported poor access to care demonstrated higher likelihood of pain prevalence than their heterosexual cisgender counterparts. In this commentary, we explore minority stress, defined as the socially based and chronic stress associated with stigma, fear of discrimination, and prejudice, as a possible contributing factor to this higher prevalence of pain among those with intersecting marginalized identities, through its effect on biological function and symptoms. The findings of Boehmer and colleagues' study underscore the need to further explore intersectional approaches to pain management in cancer care and research. See related article by Boehmer et al., p. 1309.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Survival Analysis
Ethnic Identity within a Larger Culture
The Tumor Microenvironment
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...